Remarkably, most samples harbored activating alterations in receptor tyrosine kinases (RTKs), including frequent co-amplifications and fusions of the KDR and KIT genes located on 4q12, as well as other mutations involving p53, cell cycle regulators, and genes frequently mutated in glioblastoma (Fig. 3B). The gene discussed is TP53; the disease is glioblastoma.